Genetic Diseases and Disorders Codexery

2q37 monosomy

Rare genetic disorder from terminal deletion of chromosome 2q37.

2q37 monosomy

2q37 monosomy is a rare genetic disorder caused by a deletion of a segment at the end of chromosome 2. It is characterized by intellectual disability, facial dysmorphism, and behavioral problems, with brachymetaphalangism occurring in about half of cases. The condition shows striking phenotypic variability, and the size of the deletion does not reliably predict prognosis.

field
Medical genetics
known_for
Rare genetic disorder from terminal deletion of chromosome 2q37
genetic_cause
Deletion of a segment at the end of chromosome 2
minimal_deletion_region
3 megabase region containing GPR35, GPC1, STK25
key_feature
Intellectual disability and facial dysmorphism

Lore & Background

2q37 monosomy is a rare genetic disorder caused by a deletion of a segment at the end of chromosome 2. Almost all people with this syndrome have some degree of intellectual disability and facial dysmorphism, including a round face, deep-set eyes, and thin upper lip. Behavioral problems are common. Brachymetaphalangism, or shortening of the metacarpal or metatarsal bones, is reported in approximately 50% of cases overall, but is typically not evident below the age of 2 years.

Reader's Guide

The significance of 2q37 monosomy lies in its genetic characterization and clinical variability. The minimal deletion causing the syndrome has been defined as a 3 megabase region containing the genes GPR35, GPC1, and STK25. Almost all deletions are terminal deletions at the end of chromosome 2. There is a high frequency of de novo deletions, but multiple cases within a single family are also observed. Equal proportions of maternally and paternally derived rearrangements were seen in one series. No common breakpoints for the deletion were identified, indicating that the rearrangement is unlikely to be mediated by non-homologous recombination and low-copy repeats. In a study of 20 patients, no clear relationship was found between clinical features and the size or position of the monosomic region. The size and extent of the deleted region cannot be used as reliable indicators of prognosis due to the striking phenotypic variability. Some patients have additional problems such as congenital heart disease and seizures. This disorder highlights the challenges of genotype-phenotype correlation in rare chromosomal deletions.

Did You Know?

Clinical Presentation & Physical Features

2q37 monosomy manifests through a constellation of physical and developmental features that affect nearly every individual carrying the deletion. Intellectual disability of varying severity is a near-universal hallmark, accompanied by a recognizable facial profile: a round face, deeply set eyes, and a characteristically thin upper lip. Behavioural difficulties further complicate daily life for affected individuals. A distinctive skeletal finding, brachymetaphalangism—shortening of the metacarpal or metatarsal bones—appears in roughly half of all cases, though it typically remains undetectable until after the second birthday, making early diagnosis challenging. Beyond these core features, some patients develop additional complications including congenital heart defects and seizure disorders. The breadth of possible manifestations means that no two individuals with 2q37 monosomy present in exactly the same way, and clinicians must remain attentive to the full spectrum of potential findings when evaluating a child with overlapping symptoms.

Genetic Architecture of the Deletion

The genetic architecture of 2q37 monosomy centers on a terminal deletion at the very end of chromosome 2. Researchers have identified a minimal critical region of approximately three megabases that encompasses the genes GPR35, GPC1, and STK25; loss of this segment is sufficient to produce the syndrome. The vast majority of confirmed deletions are terminal, meaning they extend to the chromosome's end rather than excising an internal chunk. Notably, no consistent breakpoints have been identified across cases, which strongly suggests the rearrangement is not driven by non-homologous recombination or low-copy repeat sequences. Instead, the deletions appear to arise through diverse molecular mechanisms, explaining the wide variation in deleted segment sizes observed among patients and reinforcing that this is not a single, mechanistically uniform event.

Prognosis & Phenotypic Variability

One of the most clinically significant aspects of 2q37 monosomy is the striking phenotypic variability among affected individuals. Despite the deletion always occurring at the same chromosomal location, the size and precise extent of the missing segment cannot be used as a reliable predictor of how severely a person will be affected. In a study examining twenty patients, researchers found no clear correlation between the clinical features a child displayed and either the size or the exact position of the monosomic region. This means that a smaller deletion does not guarantee a milder course, nor does a larger one ensure a more severe one. For families seeking to understand what the future may hold for their child, this unpredictability poses a particular challenge. Genetic counselors and clinicians must therefore frame expectations around the broad range of possible outcomes rather than a single trajectory, and must resist the temptation to read prognosis directly from the length of the deleted segment.

Inheritance Patterns & Family Occurrence

The inheritance patterns of 2q37 monosomy present a mixed picture that complicates genetic counseling. A high proportion of cases arise de novo, meaning the deletion occurs spontaneously in the affected child without being inherited from either parent. Nevertheless, multiple affected individuals within a single family have been documented, indicating that the condition can occasionally be passed down through generations. In Aldred's series, maternally and paternally derived rearrangements appeared in roughly equal proportions, ruling out a strong parental bias in transmission. The absence of shared breakpoints across cases further underscores that the deletion does not follow a single, predictable genetic pathway. For families navigating recurrence risk, these findings suggest that while most cases are isolated events, the possibility of familial transmission—though uncommon—must be acknowledged, and careful genetic evaluation of both parents is warranted to determine whether a balanced rearrangement might be present.

Gallery

Frequently Asked Questions

What is 2q37 monosomy?

It is a rare chromosomal condition that occurs when the terminal segment of the long arm of chromosome 2 is lost. The core clinical picture centers on cognitive difficulties, recognizable facial differences, and behavioral challenges.

What's the genetic 'origin story' behind 2q37 monosomy?

The condition arises from a deletion at the very tip of 2q, with the smallest known critical stretch spanning roughly three megabases that harbors genes including GPR35, GPC1, and STK25. It is classified within medical genetics as a rare structural chromosome variant.

What are 2q37 monosomy's signature traits?

The hallmark features are intellectual disability paired with distinctive facial dysmorphism, while roughly half of affected individuals also develop brachymetaphalangism, a shortening of the middle finger phalanges. Behavioral difficulties round out the typical presentation.

How does 2q37 monosomy's 'story arc' differ between individuals?

Phenotypic variability is a defining trait of this condition, meaning two people carrying the same deletion can present with markedly different severity and feature combinations. Strikingly, the length of the missing segment does not reliably forecast the clinical outcome.

Why does 2q37 monosomy matter in the broader genetics field?

It serves as a key example of how a single terminal chromosomal loss can produce a wide spectrum of effects, challenging the assumption that deletion size alone determines severity. Studying it helps refine our understanding of gene dosage and critical regions on chromosome 2.

More in Genetic diseases and disorders 1-24

Spotted an error? Know more?

This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record

Comments

Loading…
Open in the interactive codex →